Related Experiment Video

Updated: Dec 20, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.1K

Designing antifilarial drug trials using clinical trial simulators

Martin Walker1,2, Jonathan I D Hamley3,4, Philip Milton3,4

  • 1London Centre for Neglected Tropical Disease Research, Department of Pathobiology and Population Sciences, Royal Veterinary College, University of London, Hertfordshire, AL9 7TA, UK. mwalker@rvc.ac.uk.

Nature Communications
|June 3, 2020
PubMed

Insights

Clinical trial simulators can optimize the design of studies for neglected tropical diseases like lymphatic filariasis and onchocerciasis. This approach helps improve drug development and intervention strategies for these widespread infections.

Area of Science:

  • Tropical medicine
  • Parasitology
  • Computational biology

Background:

  • Lymphatic filariasis and onchocerciasis are neglected tropical diseases (NTDs) targeted for elimination through mass drug administration.
  • Current antifilarial drugs primarily target microfilariae, necessitating new therapies for persistent transmission hotspots.
  • Clinical trial simulators (CTSs) offer potential benefits for NTD research but are underutilized.

Purpose of the Study:

  • To demonstrate the utility of CTSs in designing clinical trials for NTDs.
  • To project the outcomes of a hypothetical macrofilaricidal drug for onchocerciasis.
  • To inform target product profiles and optimize intervention strategies.

Main Methods:

  • Utilized an individual-based onchocerciasis transmission model (EPIONCHO-IBM) as a CTS.
  • Simulated clinical trial outcomes for a hypothetical macrofilaricidal drug.
  • Analyzed the impact of key trial design parameters on study power.

Main Results:

  • Identified critical trial design decisions influencing study power, such as participant eligibility and follow-up duration.
  • Demonstrated that CTSs can effectively project patient outcomes for antifilarial drug trials.
  • Highlighted the role of CTSs in refining target product profiles for new NTD therapies.

Conclusions:

  • CTSs are valuable tools for optimizing clinical trial design in neglected tropical diseases.
  • Simulation-based approaches can enhance the efficiency and effectiveness of drug development for lymphatic filariasis and onchocerciasis.
  • Informing trial design through CTSs can accelerate progress towards the elimination of these NTDs.

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.7K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
183
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.7K